Anvajo raises 17.7 million euros
The health tech company from Dresden thus successfully closes its Series A round.
In its Series A financing round, the Dresden-based health tech start-up receives a total of 17.7 million euros. The investors include Medice Arzneimittel, Elber Beteiligungen and Think.Health from Germany as well as Johnsoville Ventures from the USA. The existing investor, Die BrückenköpfeX, also provided additional funds. The new capital is intended to accelerate the company's launch, particularly in the human medicine markets.
In 2016, founder Stefan Fraedrich wanted to use Anvajo to develop a platform technology for the prevention, monitoring and screening of chronic kidney disease. The idea was simply to use fewer devices for diagnosis. He founded his start-up as a spin-off from the Technical University of Dresden. According to Anvajo, the technology for analyzing fluids is already being used in two devices in veterinary medicine and science. In rural areas in particular, the analysis method should provide relief in the future.
Newsletter
Startups, stories and stats from the German startup ecosystem straight to your inbox. Subscribe with 2 clicks. Noice.
LinkedIn ConnectFYI: English edition available
Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?
FYI: Deutsche Edition verfügbar
Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?
